Malaria continues to be a significant public health challenge in Myanmar, particularly affecting vulnerable groups such as children under five and pregnant women in the eastern and western border regions.
The Yanomami Indigenous people, in Roraima, became the first patients in Brazil to receive tafenoquine and point-of-care glucose-6-phosphate dehydrogenase (G6PD) testing for P. vivax malaria, following the decision of the government to adopt the use of these new health technology innovations
Research Roundup: A safe, effective TB treatment, partnership to end malaria, and COVAX marketplace ghtcoalition.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ghtcoalition.org Daily Mail and Mail on Sunday newspapers.
New partnership to improve treatment and diagnostic of relapsing malaria in Asia biospectrumasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumasia.com Daily Mail and Mail on Sunday newspapers.